Furthermore, by addressing key components of metabolic syndrome, GLP-1 RAs contribute to a broader, integrated strategy for reducing overall CV morbidity and mortality in this high-risk population, including an increment in physical activity openness [10]. This evidence concerns the gene GCG and metabolic syndrome.